Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 202761

Expand all

DOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE)
EQ 3MG BASE
Marketing Status: Discontinued

Active Ingredient: DOXEPIN HYDROCHLORIDE
Proprietary Name: DOXEPIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 3MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202761
Product Number: 001
Approval Date: Aug 16, 2023
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

DOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE)
EQ 6MG BASE
Marketing Status: Discontinued

Active Ingredient: DOXEPIN HYDROCHLORIDE
Proprietary Name: DOXEPIN HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 6MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A202761
Product Number: 002
Approval Date: Aug 16, 2023
Applicant Holder Full Name: ZYDUS PHARMACEUTICALS USA INC
Marketing Status:  Discontinued
Patent and Exclusivity Information